Literature DB >> 18166354

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia.

Anil Mishra1, Meiqin Wang, Venkatarajani R Pemmaraju, Margaret H Collins, Patricia C Fulkerson, J Pablo Abonia, Carine Blanchard, Philip E Putnam, Marc E Rothenberg.   

Abstract

BACKGROUND & AIMS: Eosinophilic esophagitis (EE) is an increasingly recognized disease that mimics gastroesophageal reflux disease. Recently, EE has been associated with esophageal remodeling, but the mechanisms involved are poorly understood. We hypothesized that the development of EE in patients and in an experimental murine model would be associated with eosinophil-mediated tissue remodeling.
METHODS: Histopathologic analysis of basal layer thickness and collagen accumulation was performed on the biopsy specimens of normal individuals, EE patients, and mouse esophageal tissue sections following experimental induction of EE in wild-type, eosinophil lineage-deficient, interleukin (IL)-5-deficient, and IL-5 transgenic mice, with the latter 2 mice groups having decreased and increased esophageal eosinophilia, respectively.
RESULTS: An impressive accumulation of collagen in the epithelial mucosa and lamina propria, as well as basal layer thickening, was observed in the esophagus of patients with EE as well as in mice with experimental EE compared with controls. Significantly reduced lamina propria collagen and basal layer thickness were observed in IL-5-deficient mice and eosinophil lineage-deficient mice compared with wild-type mice following the induction of experimental EE. Furthermore, the esophagus of CD2-IL-5 transgenic mice showed increased basal layer thickness and collagen accumulation compared with nontransgenic mice, yet IL-5 intestine transgenic mice did not have EE-like esophageal changes. Additional analysis revealed increased IL-5 levels in the esophagus of EE patients, allergen-challenged wild-type mice, and CD2-IL-5 transgenic mice but not in IL-5 intestine transgenic mice.
CONCLUSIONS: These findings provide evidence that local IL-5-mediated eosinophilia is essential in the induction of esophageal remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18166354      PMCID: PMC2654267          DOI: 10.1053/j.gastro.2007.10.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  A critical role for eosinophils in allergic airways remodeling.

Authors:  Alison A Humbles; Clare M Lloyd; Sarah J McMillan; Daniel S Friend; Georgina Xanthou; Erin E McKenna; Sorina Ghiran; Norma P Gerard; Channing Yu; Stuart H Orkin; Craig Gerard
Journal:  Science       Date:  2004-09-17       Impact factor: 47.728

Review 2.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

Authors:  P K Jeffery; A J Wardlaw; F C Nelson; J V Collins; A B Kay
Journal:  Am Rev Respir Dis       Date:  1989-12

4.  Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?

Authors:  Alex Straumann; Livio Rossi; Hans-Uwe Simon; Pius Heer; Hans-Peter Spichtin; Christoph Beglinger
Journal:  Gastrointest Endosc       Date:  2003-03       Impact factor: 9.427

5.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

Review 6.  Reflux esophagitis: sequelae and differential diagnosis in infants and children including eosinophilic esophagitis.

Authors:  Beverly Barrett Dahms
Journal:  Pediatr Dev Pathol       Date:  2004 Jan-Feb

7.  Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years.

Authors:  Alex Straumann; Hans-Peter Spichtin; Leticia Grize; Kathleen A Bucher; Christoph Beglinger; Hans-Uwe Simon
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Reduced airway inflammation and remodeling in parallel with mucin 5AC protein expression decreased by s-carboxymethylcysteine, a mucoregulant, in the airways of rats exposed to sulfur dioxide.

Authors:  Sumihisa Sueyoshi; Yuki Miyata; Yoshihiro Masumoto; Yuji Ishibashi; Shigeki Matsuzawa; Naoki Harano; Kiyoyuki Tsuru; Shigeru Imai
Journal:  Int Arch Allergy Immunol       Date:  2004-06-17       Impact factor: 2.749

9.  Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis.

Authors:  Richard J Noel; Philip E Putnam; Margaret H Collins; Amal H Assa'ad; Jesus R Guajardo; Sean C Jameson; Marc E Rothenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

Review 10.  Eosinophilic gastrointestinal disorders (EGID).

Authors:  Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

View more
  99 in total

Review 1.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 2.  Chronic Pancreatitis and the Development of Pancreatic Cancer.

Authors:  Hemanth K Kandikattu; Sathisha U Venkateshaiah; Anil Mishra
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

Review 3.  Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2015-02-07       Impact factor: 22.682

Review 4.  Eosinophilic esophagitis: concepts, controversies, and evidence.

Authors:  Philip E Putnam; Marc E Rothenberg
Journal:  Curr Gastroenterol Rep       Date:  2009-06

5.  Esophageal human β-defensin expression in eosinophilic esophagitis.

Authors:  Shauna Schroeder; Zachary D Robinson; Joanne C Masterson; Lindsay Hosford; Wendy Moore; Zhaoxing Pan; Rachel Harris; Rhonda F Souza; Stuart Jon Spechler; Sophie A Fillon; Glenn T Furuta
Journal:  Pediatr Res       Date:  2013-02-05       Impact factor: 3.756

6.  Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.

Authors:  C Blanchard; M K Mingler; M McBride; P E Putnam; M H Collins; G Chang; K Stringer; J P Abonia; J D Molkentin; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

Review 7.  Allergic mechanisms in eosinophilic esophagitis.

Authors:  Joshua B Wechsler; Paul J Bryce
Journal:  Gastroenterol Clin North Am       Date:  2014-03-22       Impact factor: 3.806

8.  Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis.

Authors:  Ma Paz Zafra; Natally Cancelliere; Pablo Rodríguez del Río; Mónica Ruiz-García; Laura Estévez; Victoria Andregnette; Silvia Sánchez-García; Ana Fiandor; Elena Collantes; Joaquín Sastre; Santiago Quirce; María Dolores Ibáñez; Victoria del Pozo
Journal:  J Gastroenterol       Date:  2012-12-11       Impact factor: 7.527

Review 9.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

10.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.